Busulfan Monotherapy as Conditioning for Autologous Hematopoietic Progenitor Cell Transplantation

NCT00363467 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

3

Enrollment

OTHER

Sponsor class

Stopped Low accrual

Conditions

Acute Myeloid Leukemia (AML)

Interventions

DRUG: G-CSF
DRUG: Leukapheresis
DRUG: Busulfan
PROCEDURE: Stem cell reinfusion

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Collaborators

[object Object]